GENENTECH/ ROCHE’s EXPENSIVE CANCER DRUG AVASTIN caused a firestorm for compounding pharmacies. Compounding pharmacies diluted Avastin for use for Macular Degeneration, to avoid the repurposed Roche Avastin-mimick Lucentis. Diluted Avastin cost 50 USD per shot vs 2,000 USD for Lucentis. Unfortunately, due to a small but serious group of eye infections, FDA understandably came down hard. We now risk throwing out the baby with the bathwater, to the likely delight of the innovator.
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022